SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Article References

GUENDLER, Vera Zukerman et al. Fatores associados ao uso excessivo de medicação sintomática em pacientes com enxaqueca crônica. Einstein (São Paulo) [online]. 2012, vol.10, n.3, pp. 312-317. ISSN 1679-4508.  http://dx.doi.org/10.1590/S1679-45082012000300010.

    1. Tulen JH, Stronks DL, Bussmann JB, Pepplinkhuizen L, Passchier J. Towards an objective quantitative assessment of daily functioning in migraine: a feasibility study. Pain. 2000;86(1-2):139-49. [ Links ]

    2. Bigal ME, Fernandes LC, Moraes FA, Bordini CA, Speciali JG. [Migraine prevalence and impact in employees of the clinical hospital of the medical school of Ribeirao Preto-USP]. Arq Neuropsiquiatr. 2000;58(2B):431-6. Portuguese. [ Links ]

    3. Silberstein SD, Olesen J, Bousser MG, Diener HC, Dodick D, First M, Goadsby PJ, Göbel H, Lainez MJ, Lance JW, Lipton RB, Nappi G, Sakai F, Schoenen J, Steiner TJ; International Headache Society. The International Classification of Headache Disorders, 2nd Edition (ICHD-II)--revision of criteria for 8.2 Medication-overuse headache. Cephalalgia. 2005;25(6):460-5. [ Links ]

    4. Headache Classification Committee, Olesen J, Bousser MG, Diener HC, Dodick D, First M, et al. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia. 2006;26(6):742-6. [ Links ]

    5. Mathew NT, Stubits E, Nigam MP. Transformation of episodic migraine into daily headache: analysis of factors. Headache. 1982;22(2):66-8. [ Links ]

    6. Dyb G, Holmen TL, Zwart JA. Analgesic overuse among adolescents with headache: the Head-HUNT-Youth Study. Neurology. 2006;66(2):198-201. [ Links ]

    7. Diener HC, Limmroth V. Medication-overuse headache: a worldwide problem. Lancet Neurol. 2004;3(8):475-83. [ Links ]

    8. Zwart JA, Dyb G, Hagen K, Svebak S, Holmen J. Analgesic use: a predictor of chronic pain and medication overuse headache: the Head-HUNT Study. Neurology. 2003;61(2):160-4. [ Links ]

    9. Saper JR, Lake AE 3rd. Medication overuse headache: type I and type II. Cephalalgia. 2006;26(10):1262. [ Links ]

    10. Lake AE 3rd. Medication overuse headache: biobehavioral issues and solutions. Headache. 2006;46 Suppl 3:S88-97. [ Links ]

    11. Mathew NT. Transformed migraine. Cephalalgia.1993;13 Suppl 12:78-83. [ Links ]

    12. Mercante JP, Peres MF, Guendler V, Zukerman E, Bernik MA. Depression in chronic migraine: severity and clinical features. Arq Neuropsiquiatr. 2005;63(2A):217-20. [ Links ]

    13. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51(1):8-19. [ Links ]

    14. First MB, Spitzer RL, Gibbon M, Williams JB. Structured clinical interview for DSM-IV axis I disorders: patient edition (SCID I/P, version 2.0). New York: Biometrics Research Department, New York State Psychiatric Institute; 1995. [ Links ]

    15. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington: American Psychiatric Association; 2000. [ Links ]

    16. Stewart WF, Lipton RB, Whyte J, Dowson A, Kolodner K, Liberman JN, et al. An international study to assess reliability of the Migraine Disability Assessment (MIDAS) score. Neurology. 1999;53(5):988-94. [ Links ]

    17. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32(1):50-5. [ Links ]

    18. Spielberger CD, Gorsuch RL, Lushene RE. Manual for the State-Trait Anxiety Inventory. Palo Alto (CA): Consulting Psychologists Press; 1970. [ Links ]

    19. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4(6):561-71. [ Links ]

    20. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23(1):56-62. [ Links ]

    21. Rasmussen BK, Jensen R, Schroll M, Olesen J. Epidemiology of headache in a general population--a prevalence study. J Clin Epidemiol. 1991;44(11):1147-57. [ Links ]

    22. Bigal, ME, Rapoport AM, Sheftell FD, Tepper SJ, Lipton RB. Transformed migraine and medication overuse in a tertiary headache centre--clinical characteristics and treatment outcomes. Cephalalgia. 2004;24(6):483-90. [ Links ]

    23. Granella F, Farina S, Malferrari G, Manzoni GC. Drug abuse in chronic headache: a clinic-epidemiologic study. Cephalalgia. 1987;7(1):15-9. [ Links ]

    24. Castillo J, Muñoz P, Guitera V, Pascual J. Kaplan Award 1998. Epidemiology of chronic daily headache in the general population. Headache. 1999;39(3):190-6. [ Links ]

    25. Isler H. Headache drugs provoking chronic headache: historical aspects and common misunderstandings. In: Diener HC, Wilkinson M. Drug-induced headache. Berlin: Springer-Verlag; 1988. p. 87-94. [ Links ]

    26. Schoenen J, Lenarduzzi P, Sianard-Gainko J. Chronic headaches associated with analgesics and/or ergotamine abuse: a clinical survey of 434 consecutive outpatients. In: Rose FC. New advances in headache research. London: Smith- Gordon; 1989. p. 255-9. [ Links ]

    27. Mathew NT, Kurman R, Perez F. Drug induced refractory headache--clinical features and management. Headache. 1990;30(10):634-8. [ Links ]

    28. Hering R, Steiner TJ. Abrupt outpatient withdrawal of medication in analgesic-abusing migraineurs. Lancet. 1991;337(8755):1442-3. [ Links ]

    29. Silberstein SD, Lipton RB, Dalessio DJ (editors). Wolff's headache and other head pain. 7th ed. Oxford: University Press; 2001. [ Links ]

    30. Spierings EL, Schroevers M, Honkoop PC, Sorbi M. Presentation of chronic daily headache: a clinical study. Headache. 1998;38(3):191-6. [ Links ]

    31. Radat F, Creac'h C, Swendsen JD, Lafittau M, Irachabal S, Dousset V, et al. Psychiatric comorbidity in the evolution from migraine to medication overuse headache. Cephalalgia. 2005;25(7):519-22. [ Links ]

    32. Regier DA, Myers JK, Kramer M, Robins LN, Blazer DG, Hough RL, et al. The NIMH Epidemiologic Catchment Area program. Historical context, major objectives, and study population characteristics. Arch Gen Psychiatry. 1984;41(10):934-41. [ Links ]

    33. Jetty PV, Charney DS, Goddard AW. Neurobiology of generalized anxiety disorder. Psychiatr Clin North Am. 2001;24(1):75-97. [ Links ]

    34. Corchs F, Mercante JP, Guendler VZ, Vieira DS, Masruha MR, Moreira FR, et al. Phobias, other psychiatric comorbidities and chronic migraine. Arq. Neuropsiquiatr. 2006;64(4):950-3. [ Links ]

    35. Peres MF, Mercante JP, Guendler VZ, Corchs F, Bernik MA, Zukerman E, et al. Cephalalgiaphobia: a possible specific phobia of illness. J Headache Pain. 2007;8(1):56-9. [ Links ]

    36. Breslau N, Lipton RB, Stewart WF, Schultz LR, Welch KM. Comorbidity of migraine and depression: investigating potential etiology and prognosis. Neurology. 2003;60(8):1308-12. [ Links ]